289 related articles for article (PubMed ID: 21272174)
1. Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.
Slavin MA; Lingaratnam S; Mileshkin L; Booth DL; Cain MJ; Ritchie DS; Wei A; Thursky KA;
Intern Med J; 2011 Jan; 41(1b):102-9. PubMed ID: 21272174
[TBL] [Abstract][Full Text] [Related]
2. Use of empiric antimicrobial therapy in neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee.
Tam CS; O'Reilly M; Andresen D; Lingaratnam S; Kelly A; Burbury K; Turnidge J; Slavin MA; Worth LJ; Dawson L; Thursky KA;
Intern Med J; 2011 Jan; 41(1b):90-101. PubMed ID: 21272173
[TBL] [Abstract][Full Text] [Related]
3. Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Australian Consensus Guidelines 2011 Steering Committee.
Lingaratnam S; Slavin MA; Koczwara B; Seymour JF; Szer J; Underhill C; Prince M; Mileshkin L; O'Reilly M; Kirsa SW; Bennett CA; Davis ID; Morrissey O; Thursky KA;
Intern Med J; 2011 Jan; 41(1b):75-81. PubMed ID: 21272171
[TBL] [Abstract][Full Text] [Related]
4. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
Jarque I; Sanz MA
Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
[TBL] [Abstract][Full Text] [Related]
5. Use of risk stratification to guide ambulatory management of neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee.
Worth LJ; Lingaratnam S; Taylor A; Hayward AM; Morrissey S; Cooney J; Bastick PA; Eek RW; Wei A; Thursky KA;
Intern Med J; 2011 Jan; 41(1b):82-9. PubMed ID: 21272172
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider.
Lo N; Cullen M
Hematol Oncol; 2006 Sep; 24(3):120-5. PubMed ID: 16783844
[TBL] [Abstract][Full Text] [Related]
7. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
Bucaneve G; Micozzi A; Menichetti F; Martino P; Dionisi MS; Martinelli G; Allione B; D'Antonio D; Buelli M; Nosari AM; Cilloni D; Zuffa E; Cantaffa R; Specchia G; Amadori S; Fabbiano F; Deliliers GL; Lauria F; Foà R; Del Favero A;
N Engl J Med; 2005 Sep; 353(10):977-87. PubMed ID: 16148283
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial prophylaxis in patients with cancer and neutropenia.
Pasqualotto AC; Rosa DD; Machado AL
N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395830
[No Abstract] [Full Text] [Related]
9. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic antimicrobial agents and the importance of fitness.
Baden LR
N Engl J Med; 2005 Sep; 353(10):1052-4. PubMed ID: 16148291
[No Abstract] [Full Text] [Related]
11. Antibacterial prophylaxis in patients with cancer and neutropenia.
Almyroudis NG; Segal BH
N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395832
[No Abstract] [Full Text] [Related]
12. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
Delarive P; Baumgartner JD; Glauser MP; Cometta A
Schweiz Med Wochenschr; 2000 Dec; 130(48):1837-44. PubMed ID: 11132527
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
Mullen CA
Pediatr Infect Dis J; 2003 Dec; 22(12):1138-42. PubMed ID: 14688588
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
Cullen M; Steven N; Billingham L; Gaunt C; Hastings M; Simmonds P; Stuart N; Rea D; Bower M; Fernando I; Huddart R; Gollins S; Stanley A;
N Engl J Med; 2005 Sep; 353(10):988-98. PubMed ID: 16148284
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
Chong Y; Yakushiji H; Ito Y; Kamimura T
Int J Infect Dis; 2011 Apr; 15(4):e277-81. PubMed ID: 21324723
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolone prophylaxis in patients with neutropenia.
Zinner SH
Clin Infect Dis; 2005 Apr; 40(8):1094-5. PubMed ID: 15791506
[No Abstract] [Full Text] [Related]
17. Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients.
Bow EJ
Curr Opin Infect Dis; 2011 Dec; 24(6):545-53. PubMed ID: 22001945
[TBL] [Abstract][Full Text] [Related]
18. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
[TBL] [Abstract][Full Text] [Related]
19. Management of the febrile neutropenic patient.
Picazo JJ;
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
[TBL] [Abstract][Full Text] [Related]
20. [Antimicrobial prophylaxis and therapy in neutropenia].
Link H
Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
